Author:
Incorvaia Lorena,Badalamenti Giuseppe,Rizzo Sergio,Bazan Viviana,Russo Antonio,Gronchi Alessandro,Dumitra Sinziana
Publisher
Springer International Publishing
Reference67 articles.
1. De Matteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–8.
2. ESMO Guidelines Committee and EUROCAN. Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv1–iv17.
3. Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33(5):33459–65.
4. Nannini M, Nigro MC, Vincenzi B, et al. Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice. Ther Adv Med Oncol. 2017;9(12):731–9. https://doi.org/10.1177/1758834017742627.
5. Badalamenti G, Barraco N, Incorvaia L, et al. Are long noncoding rnas new potential biomarkers in gastrointestinal stromal tumors (GISTs). The role of H19 and MALAT1. J Oncol. 2019;2019:5458717. Published 2019 Nov 15. https://doi.org/10.1155/2019/5458717.